Skip to main content

Pyruvate Kinase Activator

Pyruvate kinase activators are used to treat hemolytic anemia. Pyruvate kinase activators work by increasing pyruvate kinase activity, and in turn, increasing the amount of energy available to cells.

Why are pyruvate kinase activator prescribed?

  1. Anemia (50%)
  2. Thalassemia (50%)

Key takeaways

Pyruvate kinase activators are used to treat anemia caused by pyruvate kinase deficiency, a rare genetic disorder that affects red blood cells. These medications work by activating the pyruvate kinase enzyme, which helps improve the energy production in red blood cells, reducing symptoms of anemia. An example of this type of medication is mitapivat (Pyrukynd), which is available in oral form.

Prices for popular Pyruvate Kinase Activator medications
Viewing 2 of 2 medications
carton icon

Pyrukynd

as low as$26,377
MITAPIVAT treats hemolytic anemia caused by pyruvate kinase deficiency. It works by stopping red blood cells from breaking down too quickly. This decreases symptoms and the need for blood transfusions.
See pricesMore info
carton icon

Aqvesme

as low as$34,390
Aqvesme is only available as a brand name drug.
See prices
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men's health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.
ABCDEFGHIJKLMNOPQRSTUVWXYZ